To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04679064
Title Trial on NIraparib-TSR-042 (Dostarlimab) vs Physician's Choice CHEmotherapy in Recurrent, Ovarian, Fallopian Tube or Primary Peritoneal Cancer Patients Not Candidate for Platinum Retreatment (NItCHE-MITO33)
Acronym NItCHE-MITO33
Recruitment Unknown status
Gender female
Phase Phase III
Variant Requirements No
Sponsors Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Indications
Therapies
Age Groups: senior | adult
Covered Countries ITA

Facility Status City State Zip Country Details
Azienda Ospedaliera Spedali Civili RECRUITING Brescia Italy Details
Istituto Tumori della Romagna IRST IRCCS RECRUITING Meldola Italy Details
IEO-Istituto Europeo di Oncologia RECRUITING Milan Italy Details
IRCCS Ospedale San Raffaele RECRUITING Milan Italy Details
Istituto Nazionale Tumori IRCCS Fondazione G. Pascale RECRUITING Naples Italy Details
Nuovo Ospedale degli Infermi RECRUITING Ponderano Italy Details
Fondazione Policlinico Universitario Agostino Gemelli IRCCS RECRUITING Rome 00168 Italy Details
Istituti fisioterapici Ospitalieri - Istituto Tumori Regina Elena RECRUITING Rome Italy Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field